99297-4 |
Nonverbal vocal complaints while at rest |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Nonverbal vocal complaints while at rest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99297-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Nonverb vocal complaints while at rest; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99298-2 |
Facial grimaces or winces while at rest |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Facial grimaces or winces while at rest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99298-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Grimaces/winces while at rest; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99299-0 |
Bracing while at rest |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Bracing while at rest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99299-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
993-6 |
D little o super little a Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Do sup(a) Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
993-6 |
|
|
|
|
Observation |
|
|
|
0 |
Do sup(a) Ab SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; D (little o) (little a); Dextro; Do sup(a); Do^a; Dombrock; Dombrock Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
9930-9 |
Q wave depth.lead III |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead III |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9930-9 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-III |
|
|
|
Y |
|
3; Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-III; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99300-6 |
Restlessness while at rest |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Restlessness while at rest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99300-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99301-4 |
Rubbing while at rest |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Rubbing while at rest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99301-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99302-2 |
Verbal complaints while at rest |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Verbal complaints while at rest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CNPI |
|
99302-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99303-0 |
At rest score |
Score |
^Patient |
Pt |
Qn |
CNPI |
|
ACTIVE |
At rest score [CNPI] |
|
ADD |
DefinitionDescription |
|
|
score |
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
SURVEY.CNPI |
|
99303-0 |
|
CNPI |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Point in time; QNT; Quan; Quant; Quantitative; Random; Resting; Scale; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
{score} |
|
|
|
0 |
99304-8 |
Total score |
Score |
^Patient |
Pt |
Qn |
CNPI |
|
ACTIVE |
Total score [CNPI] |
|
ADD |
DefinitionDescription |
|
|
score |
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
SURVEY.CNPI |
|
99304-8 |
|
CNPI |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.CNPI; Tot; Totl |
2.72 |
2.72 |
|
|
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
{score} |
|
|
|
0 |
99305-5 |
Checklist of nonverbal pain indicators assessment |
Imp |
^Patient |
Pt |
Nom |
CNPI |
|
ACTIVE |
Checklist of nonverbal pain indicators assessment [CNPI] |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
SURVEY.CNPI |
|
99305-5 |
|
CNPI |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
CNPI assessment; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Nonverb pain ind; Point in time; Random; Survey; SURVEY.CNPI |
2.72 |
2.72 |
|
|
|
|
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission |
|
|
|
|
|
|
0 |
99306-3 |
Choriogonadotropin.beta subunit heterophile Ab interference panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Choriogonadotropin.beta subunit heterophile Ab interference panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
99306-3 |
|
|
|
|
Order |
|
|
|
0 |
B-HCG heterph Ab intrf Pnl Ser |
|
|
|
N |
|
B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; B-HCG heterph Ab intrf; B-HCG heterph Ab intrf Pnl; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Epstein-Barr virus; HCG; Hetero; Heteroph; Hetr; Human chorionic gonadotropin; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Serum; SR; Tumor marker |
2.72 |
2.72 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
99307-1 |
Choriogonadotropin.beta subunit heterophile Ab interference |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Choriogonadotropin.beta subunit heterophile Ab interference [Presence] in Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
99307-1 |
|
|
|
|
Observation |
|
|
|
0 |
B-HCG heterph Ab intrf Ser Ql |
|
|
|
N |
|
B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; B-HCG heterph Ab intrf; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Epstein-Barr virus; HCG; Hetero; Heteroph; Hetr; Human chorionic gonadotropin; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Tumor marker |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99308-9 |
Acid alpha glucosidase cross-reactive immunologic material (CRIM) |
PrThr |
WBC |
Pt |
Ord |
IB |
|
ACTIVE |
Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Leukocytes by Immunoblot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
99308-9 |
|
IB |
|
|
Both |
|
|
|
0 |
AAG CRIM WBC Ql IB |
|
|
|
N |
|
AAG CRIM; Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Blt; Chemistry; CRIM; GAA; Glucoinvertase; Glucosidosucrase; Immune blot; Immunobl; Immunoblot; Immunol; Leukocytes; Maltase; Maltase-glucoamylase; Ordinal; Point in time; Pompe disease; PR; QL; Qual; Qualitative; Random; Reac; React; RIBA; Screen; WB; WBCs; WBLOT; West blot; West blt; Western blot; White blood cells |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99309-7 |
Acid alpha glucosidase cross-reactive immunologic material (CRIM) |
PrThr |
Tissue |
Pt |
Ord |
IB |
|
ACTIVE |
Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Tissue by Immunoblot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
99309-7 |
|
IB |
|
|
Both |
|
|
|
0 |
AAG CRIM tiss Ql IB |
|
|
|
N |
|
AAG CRIM; Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Blt; Chemistry; CRIM; GAA; Glucoinvertase; Glucosidosucrase; Immune blot; Immunobl; Immunoblot; Immunol; Maltase; Maltase-glucoamylase; Ordinal; Point in time; Pompe disease; PR; QL; Qual; Qualitative; Random; Reac; React; RIBA; Screen; WB; WBLOT; West blot; West blt; Western blot |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9931-7 |
Q wave depth.lead V1 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead V1 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9931-7 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-V1 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V1; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99310-5 |
Total score^^adjusted for age |
Score |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Total score age adjusted |
|
ADD |
DefinitionDescription |
|
|
Score |
|
|
|
|
|
|
CLIN.RISK |
|
99310-5 |
|
|
|
|
Observation |
|
|
|
0 |
Total score age-adj |
|
|
|
N |
|
adj; age-adj; CLIN; CLIN.RISK; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Total score - age adjusted; Totl |
2.72 |
2.72 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
99311-3 |
Seizure onset |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Seizure onset |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99311-3 |
|
|
|
|
Observation |
|
|
|
0 |
Seizure onset |
|
|
|
N |
|
H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99312-1 |
Seizure frequency |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Seizure frequency |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99312-1 |
|
|
|
|
Observation |
|
|
|
0 |
Seizure frequency |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99313-9 |
Time since last seizure |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Time since last seizure |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
99313-9 |
|
|
|
|
Observation |
|
|
|
0 |
Time since last seizure |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Past; Point in time; QL; Qual; Qualitative; Random; Screen |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99314-7 |
SARS coronavirus 2 RdRp gene mutation detected |
Prid |
XXX |
Pt |
Nom |
Molgen |
|
ACTIVE |
SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
99314-7 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
SARS-CoV-2 RdRp mut Spec |
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Mut; Mutations; Nominal; Other; PCR; PH; Point in time; Public Health; PublicHealth; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RdRp; SARS-CoV-2 RdRp mut; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99315-4 |
OASIS E - Intervention synopsis - DC, TRN |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
OASIS E - Intervention synopsis - DC, TRN during assessment period [CMS Assessment] |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
99315-4 |
|
CMS Assessment |
|
|
Subset |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.8 |
2.72 |
|
Organizer |
|
|
|
|
|
|
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; |
0 |
9932-5 |
Q wave depth.lead V2 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead V2 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9932-5 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-V2 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V2; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
9933-3 |
Q wave depth.lead V3 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead V3 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9933-3 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-V3 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V3; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
9934-1 |
Q wave depth.lead V4 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead V4 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9934-1 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-V4 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth Lead; Q wave Dpth L-V4; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |